Advanced Search

Submit Manuscript

Volume 17, No 10, Oct 2007

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 17 Issue 10, October 2007: 858-868

ORIGINAL ARTICLES

Rig-I-/- mice develop colitis associated with downregulation of Gαi2

Yi Wang1,*, Hong-Xin Zhang1,*, Yue-Ping Sun1, Zi-Xing Liu1, Xue-Song Liu1, Long Wang2,3, Shun-Yuan Lu2,3, Hui Kong3, Qiao-Ling Liu3, Xi-Hua Li1, Zhen-Yu Lu1, Sai-Juan Chen2, Zhu Chen2, Shi-San Bao4, Wei Dai5 and Zhu-Gang Wang1,2,3,4

1Department of Medical Genetics, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

2State Key Laboratory of Medical Genomics, Rui-Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

3Shanghai Research Center for Model Organisms, Shanghai 201203, China

4Department of Pathology, University of Sydney, Sydney, 2570 NSW, Australia

5Department of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA
Correspondence: Zhu-Gang Wang(zhugangw@shsmu.edu.cn)

RIG-I (retinoid acid-inducible gene-I), a putative RNA helicase with a cytoplasmic caspase-recruitment domain (CARD), was identified as a pattern-recognition receptor (PRR) that mediates antiviral immunity by inducing type I interferon production. To further study the biological function of RIG-I, we generated Rig-I-/- mice through homologous recombination, taking a different strategy to the previously reported strategy. Our Rig-I-/- mice are viable and fertile. Histological analysis shows that Rig-I-/- mice develop a colitis-like phenotype and increased susceptibility to dextran sulfate sodium-induced colitis. Accordingly, the size and number of Peyer's patches dramatically decreased in mutant mice. The peripheral T-cell subsets in mutant mice are characterized by an increase in effector T cells and a decrease in naïve T cells, indicating an important role for Rig-I in the regulation of T-cell activation. It was further found that Rig-I deficiency leads to the downregulation of G protein αi2 subunit (Gαi2) in various tissues, including T and B lymphocytes. By contrast, upregulation of Rig-I in NB4 cells that are treated with ATRA is accompanied by elevated Gαi2 expression. Moreover, Gαi2 promoter activity is increased in co-transfected NIH3T3 cells in a Rig-I dose-dependent manner. All these findings suggest that Rig-I has crucial roles in the regulation of Gαi2 expression and T-cell activation. The development of colitis may be, at least in part, associated with downregulation of Gαi2 and disturbed T-cell homeostasis.


Cell Research (2007) 17:858-868. doi: 10.1038/cr.2007.81; published online 25 September 2007

FULL TEXT | PDF

Browse 1569